American Healthcare REIT (NYSE:AHR) Reaches New 12-Month High - Should You Buy?

Key Points

• American Healthcare REIT (NYSE:AHR) shares reached a new 52-week high at $44.00, closing at $43.59 with a trading volume of 590 shares.
• Analysts have generally given AHR a positive outlook, with a consensus "Buy" rating and target prices ranging from $43.00 to $51.00 from various firms.
• The company reported a quarterly earnings per share (EPS) of $0.42, surpassing expectations, with a projected FY 2025 guidance of 1.640-1.680 EPS.

American Healthcare REIT, Inc. (NYSE:AHR - Get Free Report) shares reached a new 52-week high during trading on Monday . The stock traded as high as $44.00 and last traded at $43.59, with a volume of 590 shares. The stock had previously closed at $43.39.

Analyst Upgrades and Downgrades

AHR has been the subject of several analyst reports. JMP Securities upped their price objective on American Healthcare REIT from $45.00 to $50.00 and gave the company a "market outperform" rating in a research note on Friday. Weiss Ratings reaffirmed a "hold (c)" rating on shares of American Healthcare REIT in a research report on Wednesday, October 8th. UBS Group initiated coverage on American Healthcare REIT in a research note on Friday, September 19th. They set a "buy" rating and a $51.00 target price for the company. KeyCorp lifted their target price on American Healthcare REIT from $40.00 to $43.00 and gave the company an "overweight" rating in a research note on Tuesday, October 14th. Finally, Robert W. Baird assumed coverage on American Healthcare REIT in a report on Friday, July 18th. They set an "outperform" rating and a $41.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and an average target price of $45.00.

American Healthcare REIT Price Performance

The company has a quick ratio of 0.48, a current ratio of 0.48 and a debt-to-equity ratio of 0.41. The stock has a market cap of $7.31 billion, a price-to-earnings ratio of -197.13, a price-to-earnings-growth ratio of 2.23 and a beta of 0.98. The company's 50-day moving average is $41.92 and its 200-day moving average is $37.18.

American Healthcare REIT (NYSE:AHR - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.02. American Healthcare REIT had a negative net margin of 1.56% and a negative return on equity of 1.43%. The firm had revenue of $542.50 million for the quarter, compared to analysts' expectations of $539.49 million. During the same period last year, the firm earned $0.33 earnings per share. The business's revenue for the quarter was up 7.5% on a year-over-year basis. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. Equities research analysts expect that American Healthcare REIT, Inc. will post 1.41 earnings per share for the current fiscal year.

American Healthcare REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 17th. Shareholders of record on Tuesday, September 30th were issued a $0.25 dividend. The ex-dividend date of this dividend was Tuesday, September 30th. This represents a $1.00 dividend on an annualized basis and a yield of 2.3%. American Healthcare REIT's payout ratio is currently -454.55%.

Insider Activity at American Healthcare REIT

In related news, EVP Mark E. Foster sold 3,850 shares of the company's stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $41.89, for a total transaction of $161,276.50. Following the completion of the transaction, the executive vice president directly owned 59,100 shares in the company, valued at $2,475,699. This represents a 6.12% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.00% of the company's stock.

Institutional Trading of American Healthcare REIT

Several hedge funds have recently added to or reduced their stakes in the stock. Stratos Wealth Partners LTD. boosted its stake in shares of American Healthcare REIT by 57.9% in the 1st quarter. Stratos Wealth Partners LTD. now owns 16,070 shares of the company's stock valued at $487,000 after purchasing an additional 5,891 shares in the last quarter. GAMMA Investing LLC raised its holdings in American Healthcare REIT by 42.2% during the 1st quarter. GAMMA Investing LLC now owns 1,405 shares of the company's stock valued at $43,000 after buying an additional 417 shares during the last quarter. Kingswood Wealth Advisors LLC bought a new stake in American Healthcare REIT during the 1st quarter valued at $332,000. Sequoia Financial Advisors LLC bought a new stake in American Healthcare REIT during the 1st quarter valued at $476,000. Finally, Charles Schwab Investment Management Inc. raised its holdings in American Healthcare REIT by 4.2% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,235,051 shares of the company's stock valued at $67,722,000 after buying an additional 89,926 shares during the last quarter. Institutional investors own 16.68% of the company's stock.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.